Adverse events profiles of pemetrexed: a Food and Drug Administration Adverse Event Reporting System
Lei Wang, JianHang Su, Chuliang Huang, Yukun Yang, Yuanqing Xu · 2026
Read Adverse events profiles of pemetrexed: a Food and Drug Administration Adverse Event Reporting System by Lei Wang, JianHang Su, Chuliang Huang, Yukun Yang, Yuanqing Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13124966.txt.
Description
BackgroundPemetrexed is a folate-pathway-targeting antineoplastic agent widely used in non-squamous non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. We used the US Food and Drug Administration Adverse Event Reporting System (FAERS) to characterize pemetrexed-associated adverse events to inform clinical safety monitoring.MethodsPemetrexed-related reports were retrieved from the FAERS database from first quarter of 2004 through the fourth quarter of 2024.
Catalog record
| CREATOR | Lei Wang, JianHang Su, Chuliang Huang, Yukun Yang, Yuanqing Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |